Theradiag SA
EPA:ALTER.PA
Overview | Financials
Company Name | Theradiag SA |
Symbol | ALTER.PA |
Currency | EUR |
Price | 1.26 |
Market Cap | 17,291,358 |
Dividend Yield | 0% |
52-week-range | 1.18 - 2.39 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Simon Daviere |
Website | https://www.theradiag.com |
An error occurred while fetching data.
About Theradiag SA
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD